See ratings and reviews when you sign up for an account.

Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty

This study is currently Recruiting

April 2011 By Henry Ford Health System

First Recieved on June 3, 2011

Last Updated on June 8, 2011

Sponsor: Henry Ford Health System
Information provided by: Henry Ford Health System
Identifier: NCT01370460


This study aims to assess postoperative blood loss and transfusion rates in total knee replacement after one-time administration of topical tranexamic acid.

Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Inclusion Criteria: - All adult patients over age eighteen - Primary unilateral total knee arthroplasty at Henry Ford Hospital (Detroit, Michigan, United States) and Henry Ford West Bloomfield Hospital (West Bloomfield, Michigan, United States) Exclusion Criteria: - patient history of venous thromboembolic disease or coagulopathy - use of anticoagulant medications within 7 days of surgery - history of arterial embolic disease - history of Class III or IV heart failure - renal failure - intraoperative cardiovascular, pulmonary, orthopaedic, or anesthetic complication (MI, intraoperative fracture, vasopressor support, emergent intubation).


  • Investigator: Michael Laker, M.D. - Principal Investigator - Henry Ford Health System


  • Henry Ford Hospital

    Detroit, Michigan 48202 United States

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.